Oxford, United Kingdom
Around 27% of essential drugs on the FDA list are categorised as 'at risk' due to uncertain supply chains. CyanoCapture is an advanced Synthetic Biology company that is leveraging the world's fastest carbon-negative cell to synthesise drug precursor molecules at lower cost and address this problem.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for CyanoCapture on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
